Company / Total Assets
BioNexus Gene Lab Corp Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$9.3M
FY2025
5-year range
$8.7M / $11.4M
FY2021-FY2025
Trend
-11.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 7 years, ranging from $1M in FY2019 to $11M in FY2023.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -1.8%.
Declined from $11M to $9M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.8%, indicating a declining trend.
- In FY2025, total assets decreased 11.3% year-over-year.
- Peak total assets was recorded in FY2023.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.3M | -11.3% |
| FY2024 | $10.4M | -8.5% |
| FY2023 | $11.4M | +30.4% |
| FY2022 | $8.7M | -8.7% |
| FY2021 | $9.6M | -5.3% |
| FY2020 | $10.1M | +721.6% |
| FY2019 | $1.2M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026